24 studies found for:    melanoma metastatic liver | Open Studies
Show Display Options
Rank Status Study
1 Unknown  TACE With Drug Eluting Beads Loaded With Doxorubicin in Liver Metastases From Melanoma Patients
Condition: Stage IV Melanoma Patients With Unresectable Liver Metastases
Intervention: Device: TACE using Drug Eluting Beads loaded with Doxorubicin
2 Recruiting RADVAX: A Stratified Phase I/II Dose Escalation Trial of Stereotactic Body Radiotherapy Followed by Ipilimumab in Metastatic Melanoma
Condition: Metastatic Melanoma
Interventions: Drug: Ipilimumab;   Radiation: Stereotactic Body Radiation Therapy
3 Recruiting Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic Melanoma
Conditions: Liver Metastases;   Lung Metastases;   Recurrent Melanoma;   Stage IV Melanoma;   Tumors Metastatic to Brain
Interventions: Biological: ipilimumab;   Radiation: stereotactic radiosurgery;   Other: laboratory biomarker analysis
4 Recruiting An Observational Safety Study in Zelboraf (Vemurafenib)-Treated Patients With BRAF-V600 Mutation-Positive Unresectable or Metastatic Melanoma (ZeSS)
Condition: Malignant Melanoma
5 Recruiting Ipilimumab 60-month Pharmacovigilance Protocol for Advanced Melanoma Patients Who Are Hepatitis B and/or Hepatitis C Virus Positive in Taiwan
Conditions: Advanced Melanoma;   Hepatitis B;   Hepatitis C
6 Unknown  Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer
Condition: Cancer
Interventions: Drug: cyclophosphamide;   Other: laboratory biomarker analysis;   Procedure: biopsy;   Procedure: cryosurgery
7 Not yet recruiting Safety Study of Talimogene Laheraprepvec Injected Into Hepatocellular Carcinoma and Metastatic Liver Tumors
Conditions: Hepatocellular Carcinoma;   Liver Metastases
Intervention: Drug: Talimogene Laherparepvec
8 Recruiting Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery
Conditions: Male Breast Cancer;   Recurrent Melanoma;   Stage IV Breast Cancer;   Stage IV Melanoma;   Stage IV Ovarian Epithelial Cancer;   Stage IV Ovarian Germ Cell Tumor;   Unspecified Adult Solid Tumor, Protocol Specific;   Hepatocellular Carcinoma
Interventions: Drug: propranolol hydrochloride;   Other: Correlative Studies
9 Not yet recruiting A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Subjects With Solid Tumors
Conditions: Metastatic Colorectal Cancer;   Metastatic Renal Cell Carcinoma;   Metastatic Melanoma;   Brain Metastasis
Interventions: Biological: Toca 511;   Drug: Toca FC
10 Unknown  Melanoma Inhibitory Activity (MIA): A Serological Marker for Metastatic Uveal Melanoma
Conditions: Melanoma;   Radiotherapy;   Metastatic Disease
Intervention: Procedure: Treatment of metastatic disease
11 Recruiting Study of 4-Demethyl-4-cholesteryloxycarbonylpenclome in Patients With Brain Tumors
Conditions: Primary Brain Tumors;   Metastatic Malignant Neoplasm to Brain
Intervention: Drug: 4-Demethyl-4-cholestryloxycarbonylpenclomedine
12 Recruiting A Study Of PF-04518600 In Patients With Select Advanced Solid Tumors
Condition: Neoplasms
Intervention: Drug: PF-04518600
13 Recruiting Sorafenib and Radioembolization With Sir-Spheres® for the Treatment of Metastatic Ocular Melanoma
Condition: Ocular Melanoma
Interventions: Drug: Sorafenib;   Device: Radioembolization with SIR-Spheres® (Yttrium Microspheres)
14 Recruiting Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
Conditions: Adult Solid Neoplasm;   Bladder Carcinoma;   Breast Carcinoma;   Endometrial Carcinoma;   Esophageal Carcinoma;   Lung Carcinoma;   Malignant Head and Neck Neoplasm;   Melanoma;   Ovarian Neoplasm;   Renal Pelvis and Ureter Urothelial Carcinoma;   Testicular Lymphoma;   Ureter Carcinoma;   Urethral Carcinoma
Interventions: Drug: Carboplatin;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel;   Other: Pharmacological Study;   Drug: Veliparib
15 Recruiting CC-486 (Oral Azacitidine) Bioequivalence Study in Patients With Solid Tumor or Hematologic Malignancies
Conditions: Hematological Neoplasms;   Non-Hodgkin's Lymphoma;   Hodgkin's Lymphoma;   Lymphoma;   Multiple Myeloma;   Acute Myeloid Leukemia;   Leukemia;   Myelodysplastic Syndromes;   Neoplasms;   Melanoma;   Breast Cancer;   Metastatic Breast Cancer;   Non-Small Cell Lung Cancer;   Small Cell Lung Cancer;   Renal Cell Carcinoma;   Glioblastoma Multiforme;   Osteosarcoma;   Sarcoma;   Thyroid Cancer;   Genitourinary
Interventions: Drug: CC-486;   Drug: Vidaza
16 Recruiting Ph 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and Cisplatin
Conditions: Pleural Mesothelioma Malignant Advanced;   Peritoneal Mesothelioma Malignant Advanced;   Non-squamous Non-small Cell Lung Carcinoma Stage IIIB/IV (NSCLC);   Metastatic Uveal Melanoma;   Hepatocellular Carcinoma (HCC);   Glioma
Intervention: Drug: ADI-PEG 20
17 Unknown  SentoClone® Compared to Reference Treatment in Advanced Malignant Melanoma
Condition: Malignant Melanoma
Interventions: Biological: SentoClone®;   Drug: Temodal® or Dacarbazine Medac®
18 Recruiting Collecting Solid Tumor Tissue to Identify New Treatments
Conditions: Gastrointestinal Cancer;   Liver Cancer;   Pancreatic Cancer;   Melanoma
19 Not yet recruiting Pembrolizumab in Treating Patients With HIV and Relapsed, Refractory, or Disseminated Malignant Neoplasms
Conditions: AIDS-Related Non-Hodgkin Lymphoma;   Classical Hodgkin Lymphoma;   HIV Infection;   Kaposi Sarcoma;   Locally Advanced Malignant Neoplasm;   Metastatic Malignant Neoplasm;   Recurrent Hepatocellular Carcinoma;   Recurrent Hodgkin Lymphoma;   Recurrent Kaposi Sarcoma;   Recurrent Malignant Neoplasm;   Recurrent Melanoma;   Recurrent Melanoma of the Skin;   Recurrent Non-Hodgkin Lymphoma;   Recurrent Non-Small Cell Lung Carcinoma;   Refractory Hodgkin Lymphoma;   Refractory Malignant Neoplasm;   Solid Neoplasm;   Stage IIIA Hepatocellular Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIA Skin Melanoma;   Stage IIIB Hepatocellular Carcinoma;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IIIB Skin Melanoma;   Stage IIIC Hepatocellular Carcinoma;   Stage IIIC Skin Melanoma;   Stage IV Non-Small Cell Lung Cancer;   Stage IV Skin Melanoma;   Stage IVA Hepatocellular Carcinoma;   Stage IVB Hepatocellular Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab
20 Not yet recruiting Clinical Sequencing Project for Metastatic Cancer Patients for Personalized Cancer Clinic.
Conditions: Hepatocellular Carcinoma;   Melanoma;   Neuroendocrine Tumor;   Sarcoma

   Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results    Last Page
Indicates status has not been verified in more than two years